Inhibition of Human Sirtuins by in Situ Generation of an Acetylated Lysine-ADP-Ribose Conjugate

被引：57

作者：

Asaba, Tomomi ^{[1
]}

Suzuki, Takayoshi ^{[1
]}

Ueda, Rie ^{[1
]}

Tsumoto, Hiroki ^{[1
]}

Nakagawa, Hidehiko ^{[1
]}

Miyata, Naoki ^{[1
]}

机构：

[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Aichi 4678603, Japan

来源：

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 131卷 / 20期

基金：

日本学术振兴会;

关键词：

NICOTINAMIDE CLEAVAGE; PROTEIN DEACETYLASES; HISTONE DEACETYLASES; THERAPEUTIC TARGETS; INSULIN-SECRETION; THIOACETYL-LYSINE; SIR2; DEACETYLASES; ACCURATE DOCKING; STRUCTURAL BASIS; CELL-SURVIVAL;

D O I：

10.1021/ja807083y

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A new type of small-molecular sirtuin inhibitor was designed on the basis of the proposed catalytic mechanism for deacetylation of acetylated lysine substrates by sirtuins. Among the compounds thus designed and synthesized, we found that 2k, which contains an ethoxycarbonyl group at the a position to the acetamide of acetylated lysine substrate analogue 1, showed potent inhibitory activity in an in vitro assay using recombinant SIRT1, with high selectivity over SIRT2 and SIRT3. Mechanistic study by means of kinetic analysis, mass spectroscopy, and computation indicated that the enol form of compound 2k nucleophilically attacks NAD(+) in the active site of SIRTs to afford the stable compound 2k-ADP-ribose conjugate 5, leading to inhibition of the enzyme activity. Compound 2k also caused a dose-dependent increase of p53 acetylation in human colon cancer HCT116 cells, indicating inhibition of SIRT1 in the cells. These results have implications for the development of selective sirtuin inhibitors by means of mechanism-based drug design.

引用

页码：6989 / 6996

页数：8

共 54 条

[31] The Sirtuin family: therapeutic targets to treat diseases of aging [J].

Milne, Jill C. ;

Denu, John M. .

CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (01) :11-17

[32] Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1 [J].

Napper, AD ;

Hixon, J ;

McDonagh, T ;

Keavey, K ;

Pons, JF ;

Barker, J ;

Yau, WT ;

Amouzegh, P ;

Flegg, A ;

Hamelin, E ;

Thomas, RJ ;

Kates, M ;

Jones, S ;

Navia, MA ;

Saunders, J ;

DiStefano, PS ;

Curtis, R .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) :8045-8054

[33]

Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562

[34] The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase [J].

North, BJ ;

Marshall, BL ;

Borra, MT ;

Denu, JM ;

Verdin, E .

MOLECULAR CELL, 2003, 11 (02) :437-444

[35] The role of nuclear architecture in genomic instability and ageing [J].

Oberdoerffer, Philipp ;

Sinclair, David A. .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) :692-702

[36] Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease [J].

Outeiro, Tiago Fleming ;

Kontopoulos, Eirene ;

Altmann, Stephen M. ;

Kufareva, Irina ;

Strathearn, Katherine E. ;

Amore, Allison M. ;

Volk, Catherine B. ;

Maxwell, Michele M. ;

Rochet, Jean-Christophe ;

McLean, Pamela J. ;

Young, Anne B. ;

Abagyan, Ruben ;

Feany, Mel B. ;

Hyman, Bradley T. ;

Kazantsev, Aleksey G. .

SCIENCE, 2007, 317 (5837) :516-519

[37] SIRT1 regulates HIV transcription via Tat deacetylation [J].

Pagans, S ;

Pedal, A ;

North, BJ ;

Kaehlcke, K ;

Marshall, BL ;

Dorr, A ;

Hetzer-Egger, C ;

Henklein, P ;

Frye, R ;

McBurney, MW ;

Hruby, H ;

Jung, M ;

Verdin, E ;

Ott, M .

PLOS BIOLOGY, 2005, 3 (02) :210-220

[38] An epiisopicropodophyllin aza analogue via palladium-catalyzed pseudo-domino cyclization [J].

Poli, G ;

Giambastiani, G .

JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (26) :9456-9459

[39] THE EFFECT OF METHIMAZOLE ON THIOAMIDE BIOACTIVATION AND TOXICITY [J].

RUSE, MJ ;

WARING, RH .

TOXICOLOGY LETTERS, 1991, 58 (01) :37-41

[40] Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry [J].

Sauve, AA ;

Schramm, VL .

BIOCHEMISTRY, 2003, 42 (31) :9249-9256

← 1 2 3 4 5 6 →